Agomelatine versus fluoxetine in glycemic control and treating depressive and anxiety symptoms in type 2 diabetes mellitus subjects: a single-blind randomized controlled trial

BACKGROUND: Depressive and anxiety symptoms could seriously affect the quality of life of type 2 diabetes mellitus (T2DM) subjects. Currently, little is known about the efficacy and acceptability of agomelatine versus fluoxetine in treating these symptoms in T2DM subjects. Therefore, this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Che, Tingting, Teng, Xiaochun, Huang, Qun, Mu, Yanfei, Tang, Xianjun, Mu, Xiaosong, Wei, Youneng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005323/
https://www.ncbi.nlm.nih.gov/pubmed/29942131
http://dx.doi.org/10.2147/NDT.S167608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005323/
https://www.ncbi.nlm.nih.gov/pubmed/29942131
http://dx.doi.org/10.2147/NDT.S167608

Ejemplares similares